Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$690.73M
Total Bought:
$370.59M
Total Sold:
$215.64M
Net Transaction:
+$154.95M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADS(ABVX)0539,704+539,704$0$45.82M6.63%+$45.82M
Rhythm Pharmaceuticals, Inc.(RYTM)400,772369,996-30,776$25.32M$37.37M5.41%+$12.04M
Avidity Biosciences Inc410,000844,633+434,633$11.64M$36.80M5.33%+$25.16M
Nuvalent Inc235,583372,300+136,717$17.97M$32.20M4.66%+$14.22M
UroGen Pharma Ltd.(URGN)2,022,4821,577,283-445,199$27.71M$31.47M4.56%+$3.76M
Akero Therapeutics Inc713,811643,636-70,175$38.09M$30.56M4.42%-$7.53M
Insmed Incorporated(INSM)249,060206,648-42,412$25.07M$29.76M4.31%+$4.69M
Dianthus Therapeutics, Inc.(DNTH)95,806674,966+579,160$1.78M$26.56M3.85%+$24.78M
uniQure N.V.SHS(QURE)202,565455,000+252,435$2.82M$26.56M3.84%+$23.73M
CG Oncology, Inc.(CGON)541,034638,346+97,312$14.07M$25.71M3.72%+$11.65M
ORIC Pharmaceuticals, Inc.(ORIC)1,800,8291,948,808+147,979$18.28M$23.39M3.39%+$5.11M
Cidara Therapeutics Inc103,943220,902+116,959$5.06M$21.15M3.06%+$16.09M
Fractyl Health, Inc.(GUTS)202,59010,600,000+10,397,410$328.2K$16.85M2.44%+$16.53M
Kalvista Pharmaceuticals Inc1,832,1711,363,378-468,793$20.71M$16.61M2.40%-$4.11M
Kodiak Sciences Inc.(KOD)401,5401,000,000+598,460$1.50M$16.37M2.37%+$14.87M
Gossamer Bio, Inc.(GOSS)5,146,7824,779,082-367,700$6.33M$12.57M1.82%+$6.24M
Cogent Biosciences, Inc.(COGT)0815,075+815,075$0$11.70M1.69%+$11.70M
Cytokinetics, Incorporated(CYTK)0211,000+211,000$0$11.60M1.68%+$11.60M
Vaxcyte, Inc.(PCVX)287,796314,339+26,543$9.36M$11.32M1.64%+$1.97M
Biogen Inc.(BIIB)080,419+80,419$0$11.27M1.63%+$11.27M
Ascendis Pharma A/SADR(ASND)86,55253,554-32,998$14.94M$10.65M1.54%-$4.29M
Compass Therapeutics, Inc.(CMPX)1,249,7812,833,988+1,584,207$3.25M$9.92M1.44%+$6.67M
Amylyx Pharmaceuticals, Inc.(AMLX)0700,000+700,000$0$9.51M1.38%+$9.51M
Verastem, Inc.(VSTM)01,042,757+1,042,757$0$9.21M1.33%+$9.21M
Avalo Therapeutics, Inc.(AVTX)0720,922+720,922$0$9.16M1.33%+$9.16M
Olema Pharmaceuticals, Inc.(OLMA)0933,541+933,541$0$9.14M1.32%+$9.14M
Celldex Therapeutics, Inc.(CLDX)198,441348,922+150,481$4.04M$9.03M1.31%+$4.99M
Scholar Rock Holding Corporation(SRRK)341,010233,920-107,090$12.08M$8.71M1.26%-$3.37M
Veracyte, Inc.(VCYT)448,495235,791-212,704$12.12M$8.09M1.17%-$4.03M
Syndax Pharmaceuticals, Inc.(SNDX)402,964463,708+60,744$3.77M$7.13M1.03%+$3.36M
Rapport Therapeutics, Inc.(RAPP)0203,946+203,946$0$6.06M0.88%+$6.06M
Viridian Therapeutics, Inc.(VRDN)0259,509+259,509$0$5.60M0.81%+$5.60M
Alkermes plcSHS(ALKS)0180,513+180,513$0$5.42M0.78%+$5.42M
Trevi Therapeutics, Inc.(TRVI)539,587588,789+49,202$2.95M$5.39M0.78%+$2.44M
BridgeBio Oncology Therapeutics, Inc.(BBOT)0457,414+457,414$0$5.30M0.77%+$5.30M
Abeona Therapeutics Inc.(ABEO)917,898994,754+76,856$5.21M$5.25M0.76%+$38.6K
Lexeo Therapeutics, Inc.(LXEO)0778,611+778,611$0$5.17M0.75%+$5.17M
Monte Rosa Therapeutics, Inc.(GLUE)0694,942+694,942$0$5.15M0.75%+$5.15M
Compugen Ltd.(CGEN)3,033,8793,311,165+277,286$5.40M$4.87M0.70%-$532.9K
Pharvaris N V
COM
0183,903+183,903$0$4.59M0.66%+$4.59M
Celcuity Inc.(CELC)088,686+88,686$0$4.38M0.63%+$4.38M
Cerus Corporation(CERS)2,488,2912,715,786+227,495$3.51M$4.32M0.63%+$809.6K
C4 Therapeutics, Inc.(CCCC)01,897,383+1,897,383$0$4.21M0.61%+$4.21M
TELA Bio, Inc.(TELA)2,779,7952,782,923+3,128$5.39M$4.15M0.60%-$1.25M
Aardvark Therapeutics Inc286,807306,912+20,105$3.88M$4.08M0.59%+$201.2K
Bicara Therapeutics Inc0250,606+250,606$0$3.96M0.57%+$3.96M
Benitec Biopharma Inc.(BNTC)253,234276,267+23,033$2.96M$3.88M0.56%+$913.2K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)75,95988,910+12,951$2.10M$3.45M0.50%+$1.35M
Centessa Pharmaceuticals PlcADS5,000141,238+136,238$65.7K$3.43M0.50%+$3.36M
EyePoint, Inc.(EYPT)0230,837+230,837$0$3.29M0.48%+$3.29M
Sionna Therapeutics, Inc.(SION)186,015108,801-77,214$3.23M$3.20M0.46%-$27.5K
Zura Bio LimitedCL A(ZURA)0720,452+720,452$0$3.12M0.45%+$3.12M
Mineralys Therapeutics, Inc.(MLYS)115,28280,000-35,282$1.56M$3.03M0.44%+$1.47M
Erasca, Inc.(ERAS)2,569,5911,368,075-1,201,516$3.26M$2.98M0.43%-$281.0K
Praxis Precision Medicines, Inc.(PRAX)10,00051,210+41,210$420.5K$2.71M0.39%+$2.29M
Elutia Inc.CL A(ELUT)2,761,6842,850,987+89,303$5.47M$2.54M0.37%-$2.93M
Delcath Systems, Inc.(DCTH)103,026203,386+100,360$1.40M$2.19M0.32%+$785.2K
Crinetics Pharmaceuticals In050,000+50,000$0$2.08M0.30%+$2.08M
CAMP4 THERAPEUTICS CORPORATION(CAMP)0653,594+653,594$0$1.96M0.28%+$1.96M
Contineum Therapeutics, Inc.CL A(CTNM)0166,161+166,161$0$1.95M0.28%+$1.95M
Dyne Therapeutics, Inc.(DYN)0100,000+100,000$0$1.26M0.18%+$1.26M
LB Pharmaceuticals Inc(LBRX)070,000+70,000$0$1.11M0.16%+$1.11M
Mersana Therapeutics Inc0133,636+133,636$0$1.04M0.15%+$1.04M
Radiopharm Theranostics LimitedADS(RADX)187,406187,4060$869.6K$1.03M0.15%+$164.9K
Immunovant, Inc.(IMVT)050,000+50,000$0$806.0K0.12%+$806.0K
Modular Med Inc710,363639,531-70,832$529.2K$447.5K0.06%-$81.7K
Biodesix, Inc.(BDSX)049,607+49,607$0$374.5K0.05%+$374.5K
MBX Biosciences, Inc.(MBX)015,000+15,000$0$262.5K0.04%+$262.5K
Enliven Therapeutics Inc10,00010,675+675$200.6K$218.5K0.03%+$17.9K
MoonLake ImmunotherapeuticsCL A(MLTX)82,02330,000-52,023$3.87M$215.1K0.03%-$3.66M
Arcturus Therapeutics Holdings Inc.(ARCT)03,445+3,445$0$63.5K0.01%+$63.5K
Nektar Therapeutics(NKTR)346365+19$8.9K$20.8K0.00%+$11.8K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,828104,8280$3.0K$4.1K0.00%+$1.1K
89bio Inc2,037,0870-2,037,087$20.00M$0—-$20.00M
Biodesix, Inc.(BDSX)1,070,3670-1,070,367$302.1K$0—-$302.1K
Helix Acquisition Corp IiCL A613,3930-613,393$6.51M$0—-$6.51M
Mersana Therapeutics Inc3,128,4210-3,128,421$926.0K$0—-$926.0K
Merus N V741,9720-741,972$39.03M$0—-$39.03M
Metsera Inc207,5810-207,581$5.91M$0—-$5.91M
Neurocrine Biosciences, Inc.(NBIX)162,9690-162,969$20.48M$0—-$20.48M
Oruka Therapeutics, Inc.(ORKA)165,3890-165,389$1.85M$0—-$1.85M
Pfizer Inc.(PFE)344,3380-344,338$8.35M$0—-$8.35M
Sagimet Biosciences Inc.COM SER A(SGMT)37,5390-37,539$286.0K$0—-$286.0K
Soleno Therapeutics Inc204,5910-204,591$17.14M$0—-$17.14M
Structure Therapeutics IncADS175,6360-175,636$3.64M$0—-$3.64M
Tourmaline Bio Inc109,2570-109,257$1.75M$0—-$1.75M
Verona Pharma PlcADS358,2970-358,297$33.89M$0—-$33.89M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q3 2025 | TickerTrail